Literature DB >> 35261471

An unusual myeloid sarcoma.

John R Krause1, Samreen Fathima1, Rory Richard Mayer2, George J Snipes3.   

Abstract

Myeloid sarcoma is a tumor mass of immature myeloid or monocytic cells (rarely erythroid or megakaryocytic) occurring in an extramedullary site. A de novo promyelocytic granulocytic sarcoma is a very rare tumor. We report a case of a young man presenting with a paraspinal myeloid sarcoma of promyelocytic origin.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  Granulocytic sarcoma; myeloid sarcoma; promyelocytic leukemia

Year:  2021        PMID： 35261471      PMCID： PMC8865273          DOI： 10.1080/08998280.2021.1995108

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  8 in total

1.  All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Authors:  Harry J Iland; Ken Bradstock; Shane G Supple; Alberto Catalano; Marnie Collins; Mark Hertzberg; Peter Browett; Andrew Grigg; Frank Firkin; Amanda Hugman; John Reynolds; Juliana Di Iulio; Campbell Tiley; Kerry Taylor; Robin Filshie; Michael Seldon; John Taper; Jeff Szer; John Moore; John Bashford; John F Seymour
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

Review 2.  CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.

Authors:  Lisa D Burry; Jack T Seki
Journal:  Ann Pharmacother       Date:  2002-12       Impact factor: 3.154

3.  Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia--the occurrence of retinoic acid syndrome is a risk factor.

Authors:  B S Ko; J L Tang; Y C Chen; M Yao; C H Wang; M C Shen; H F Tien
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

Review 4.  Extramedullary acute promyelocytic leukemia.

Authors:  P H Wiernik; R De Bellis; P Muxi; J P Dutcher
Journal:  Cancer       Date:  1996-12-15       Impact factor: 6.860

5.  Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases.

Authors:  V Liso; G Specchia; E M Pogliani; G Palumbo; D Mininni; V Rossi; E Teruzzi; A Mestice; M R Coppi; A Biondi
Journal:  Cancer       Date:  1998-10-15       Impact factor: 6.860

6.  Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases.

Authors:  R S Neiman; M Barcos; C Berard; H Bonner; R Mann; R E Rydell; J M Bennett
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

7.  Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.

Authors:  Gil Cunha De Santis; Mirela de Barros Tamarozzi; Romualdo Barroso Sousa; Susana Elisa Moreno; Daniela Secco; Aglair Bergamo Garcia; Ana Sílvia Gouveia Lima; Lúcia Helena Faccioli; Roberto Passetto Falcão; Fernando Queirós Cunha; Eduardo Magalhães Rego
Journal:  Haematologica       Date:  2007-12       Impact factor: 9.941

8.  Acute promyelocytic leukemia presenting as recurrent spinal myeloid sarcomas 3 years before developing leukemia: A case report with review of literature.

Authors:  Tomoko Yamashita; Akihiko Nishijima; Yuma Noguchi; Kensuke Narukawa; Gaku Oshikawa; Hina Takano
Journal:  Clin Case Rep       Date:  2019-01-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.